InvestorIdeas.com is pleased to provide research
reports on the following:
Report Title: China's Health System Reform:
Implications for Drug Manufacturers
Prepared by Mr. Ki Chiu, Investment and Finance Consultant
www.investorideas.com/About/
Summary: Since mid 90s, the PRC (People Republic
of China) government has formulated and implemented a
number of new policies in a bid to reform its medical and
health industry. The medical reform aims to reduce
medical expenses, shift financial burden from the State to
corporations and improve quality of medical services,
social welfare and efficiency of resource
allocation. It is expected that demand for medical
services will rise as a result. However, the impact
of the reform on various operators in the pharmaceutical
manufacturing industry is mixed. The following is an
analysis of major government policies and their impact on
the drug manufacturers.
TOP
|
